Alzheimer's disease is the most prevalent neurodegenerative
disorder in the elderly. A recent study from the Bloomberg School
of Public Health recently estimated that over 26 million people
were living with the disease in 2006 and that the global prevalence
of the disease will grow to 106 million by 2050. By that time, 43
per cent of those living with the disease will need high-level
care, equivalent to that of a nursing home. However, even if modest
advances in preventing or delaying the disease's progression were
made, it could have a huge impact on global public health.
According to this study, interventions that could delay the onset
of the disease by as little as one year would reduce the prevalence
of the disease by 12 million fewer cases in 2050. These figures
reinforce how important it is to find an effective intervention for
Alzheimer's disease.
Emerging Drugs and Targets for Alzheimer's Disease collects some
of the most outstanding examples of new drugs currently under
pharmaceutical development or new targets in the validation process
that will reach the Alzheimer's drug market over the next few years
as disease modifying drugs.
Written by a team of distinguished experts Volume 1:
Beta-Amyloid, Tau Protein and Glucose Metabolism will be an
essential resource for scientists in the pharmaceutical and
biotechnology industries and academics working in the neurosciences
field.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
(2)
